Monitoring the activation state of insulin/insulin-like growth factor-1 hybrid receptors using bioluminescence resonance energy transfer

Molecular Pharmacology

Volumn 70, Issue 5, 2006, Pages 1802-1811

  Blanquart, Christophe ^b   Gonzalez Yanes, Carmen ^b   Issad, Tarik ^a  

^a INSTITUT COCHIN   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HYBRID PROTEIN; INSULIN; PHOSPHATASE; RENILLA LUCIFERIN 2 MONOOXYGENASE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TYROSINE; TYROSINE KINASE RECEPTOR; YELLOW FLUORESCENT PROTEIN;

ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CANCER THERAPY; CELL STRAIN HEK293; CONTROLLED STUDY; FLUORESCENCE MICROSCOPE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; PHOSPHORYLATION; PRIORITY JOURNAL;

BACTERIAL PROTEINS; DIMERIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; INSULIN; LIGANDS; LUCIFERASES, RENILLA; LUMINESCENT PROTEINS; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN TRANSPORT; RECEPTOR, IGF TYPE 1; RECOMBINANT FUSION PROTEINS;

EID: 33751196629     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.026989     Document Type: Article

References (35)

1. Angers S, Salahpour A, Joly E, Hilairet S, Chelsky D, Dennis M, and Bouvier M (2000) Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci USA 97:3684-3689.
2. Belfiore A, Pandini G, Vella V, Squatrito S, and Vigneri R (1999) Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer. Biochimie 81:403-407.
3. Blanquart C, Boute N, Lacasa D, and Issad T (2005) Monitoring the activation state of the insulin-like growth factor-1 receptor and its interaction with protein tyrosine phosphatase 1B using bioluminescence resonance energy transfer. Mol Pharmacol 68:885-894.
4. Boute N, Boubekeur S, Lacasa D, and Issad T (2003) Dynamics of the interaction between the insulin receptor and protein tyrosine-phosphatase 1B in living cells. EMBO (Eur Mol Biol Organ) Rep 4:313-319.
5. Boute N, Jockers R, and Issad T (2002) The use of resonance energy transfer in high-throughput screening: BRET versus FRET. Trends Pharmacol Sci 23:351.
6. Boute N, Pernet K, and Issad T (2001) Monitoring the activation state of the insulin receptor using bioluminescence resonance energy transfer. Mol Pharmacol 60:640-645.
7. Combettes-Souverain M and Issad T (1998) Molecular basis of insulin action. Diabetes Metab 24:477-489.
8. De Meyts P and Whittaker J (2002) Structural biology of insulin and IGF1 receptors: implications for drug design. Nat Rev Drug Discov 1:769-783.
9. Denley A, Wallace JC, Cosgrove LJ, and Forbes BE (2003) The insulin receptor isoform exon 11- (IR-A) in cancer and other diseases: a review. Horm Metab Res 35:778-785.
10. Ellis L, Clauser E, Morgan DO, Edery M, Roth RA, and Rutter WJ (1986) Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell 45:721-732.
11. Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, Goldfine ID, Belfiore A, and Vigneri R (1999) Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 19:3278-3288.
12. Frattali AL and Pessin JE (1993) Relationship between alpha subunit ligand occupancy and beta subunit autophosphorylation in insulin/insulin-like growth factor-1 hybrid receptors. J Biol Chem 268:7393-7400.
13. Frattali AL, Treadway JL, and Pessin JE (1992) Transmembrane signaling by the human insulin receptor kinase. Relationship between intramolecular β subunit trans- and cis-autophosphorylation and substrate kinase activation. J Biol Chem 267:19521-19528.
14. Issad T, Boute N, Boubekeur S, and Lacasa D (2005) Interaction of PTPB with the insulin receptor precursor during its biosynthesis in the endoplasmic reticulum. Biochimie 87:111-116.
15. Issad T, Boute N, and Pernet K (2002) A homogenous assay to monitor the activity of the insulin receptor using bioluminescence resonance energy transfer. Biochem Pharmacol 64:813-817.
16. Issad T, Combettes M, and Ferre P (1995) Isoproterenol inhibits insulin-stimulated tyrosine phosphorylation of the insulin receptor without increasing its serine/threonine phosphorylation. Eur J Biochem 234:108-115.
17. Kato H, Faria TN, Stannard B, Roberts CT Jr, and LeRoith D (1994) Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action. Mol Endocrinol 8:40-50.
18. Lacasa D, Boute N, and Issad T (2005) Interaction of the insulin receptor with the receptor-like protein tyrosine phosphatases PTPα and PTPε in living cells. Mol Pharmacol 67:1206-1213.
19. Moller DE, Yokota A, Caro JF, and Flier JS (1989) Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol Endocrinol 3:1263-1269.
20. Moss AM and Livingston JN (1993) Distinct beta-subunits are present in hybrid insulin-like-growth-factor-1 receptors in the central nervous system. Biochem J 294:685-692.
21. Mosthaf L, Grako K, Dull TJ, Coussens L, Ullrich A, and McClain DA (1990) Functionally distinct insulin receptors generated by tissue-specific alternative splicing. EMBO (Eur Mol Biol Organ) J 9:2409-2413.
22. Nouaille S, Blanquart C, Zilberfarb V, Boute N, Perdereau D, Roix J, Burnol AF, and Issad T (2006) Interaction with Grb14 results in site-specific regulation of tyrosine phosphorylation of the insulin receptor. EMBO (Eur Mol Biol Organ) Rep 7:512-518.
23. O'Connor R (2003) Regulation of IGF-I receptor signaling in tumor cells. Horm Metab Res 35:771-777.
24. Olayioye MA, Neve RM, Lane HA, and Hynes NE (2000) The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO (Eur Mol Biol Organ) J 19:3159-3167.
25. Pandini G, Frasca F, Mineo R, Sciacca L, Vigneri R, and Belfiore A (2002) Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem 277:39684-39695.
26. Pandini G, Vigneri R, Costantino A, Frasca F, Ippolito A, Fujita-Yamaguchi Y, Siddle K, Goldfine ID, and Belfiore A (1999) Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling. Clin Cancer Res 5:1935-1944.
27. Pollak MN (2004) Insulin-like growth factors and neoplasia. Novartis Found Symp 262:84-98; discussion 98-107, 265-268.
28. Sciacca L, Costantino A, Pandini G, Mineo R, Frasca F, Scalia P, Sbraccia P, Goldfine ID, Vigneri R, and Belfiore A (1999) Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism. Oncogene 18:2471-2479.
29. Soos MA, Field CE, and Siddle K (1993) Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Biochem J 290:419-426.
30. Soos MA and Siddle K (1989) Immunological relationships between receptors for insulin and insulin-like growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors. Biochem J 263:553-563.
31. Soos MA, Whittaker J, Lammers R, Ullrich A, and Siddle K (1990) Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells. Biochem J 270:383-390.
32. Vella V, Pandini G, Sciacca L, Mineo R, Vigneri R, Pezzino V, and Belfiore A (2002) A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer. J Clin Endocrinol Metab 87:245-254.
33. Vella V, Sciacca L, Pandini G, Mineo R, Squatrito S, Vigneri R, and Belfiore A (2001) The IGF system in thyroid cancer: new concepts. Mol Pathol 54:121-124.
34. Xu Y, Piston DW, and Johnson CH (1999) A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins. Proc Natl Acad Sci USA 96:151-156.
35. Yarden Y and Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127-137.